APA (7th ed.) Citation

Chida, K., Kawazoe, A., Suzuki, T., Kawazu, M., Ueno, T., Takenouchi, K., . . . Yoshino, T. (2022). Transcriptomic Profiling of MSI-H/dMMR Gastrointestinal Tumors to Identify Determinants of Responsiveness to Anti–PD-1 Therapy. Clinical cancer research, 28(10), 2110-2117. https://doi.org/10.1158/1078-0432.CCR-22-0041

Chicago Style (17th ed.) Citation

Chida, Keigo, et al. "Transcriptomic Profiling of MSI-H/dMMR Gastrointestinal Tumors to Identify Determinants of Responsiveness to Anti–PD-1 Therapy." Clinical Cancer Research 28, no. 10 (2022): 2110-2117. https://doi.org/10.1158/1078-0432.CCR-22-0041.

MLA (9th ed.) Citation

Chida, Keigo, et al. "Transcriptomic Profiling of MSI-H/dMMR Gastrointestinal Tumors to Identify Determinants of Responsiveness to Anti–PD-1 Therapy." Clinical Cancer Research, vol. 28, no. 10, 2022, pp. 2110-2117, https://doi.org/10.1158/1078-0432.CCR-22-0041.